tbuckley/cabot-search huggingface dataset:
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
Authors: Rishi J Desai, Jessica M Franklin
Journal: BMJ (2019)

This report aims to provide methodological guidance to help practitioners select the most appropriate weighting method based on propensity scores for their analysis out of many available options (eg, inverse probability treatment weights, standardised mortality ratio weights, fine stratification weights, overlap weights, and matching weights), and outlines recommendations for transparent reporting of studies using weighting based on the propensity scores.
P2.16-04 Single-Port Video-Assisted Thoracoscopic Surgery Reduces Patient-Reported Symptom Burden in Patients Undergoing Lung Resection
Authors: W. Dai, S. Xie, X. Wei, Y. Zhang, W. Feng, Y. Mu, R. Zhang, X. Liao, C. Wu, H. Zhou, X. Yang, Q. Shi, Q. Li
Journal: Journal of Thoracic Oncology (2019)
P1.13-11 An Audit on IASLC Compliance of Lymph Nodes Dissection and Impact on Survival After Surgery for Non-Small Cell Lung Cancer
Authors: P. De Sousa, F. Mansour, M. Barbosa, S. Booth, H. Klein, A. Mani, M. Nizami, C. Von Crease, G. Ladas, J. Finch, N. Asadi, E. Beddow, N. Mcgonigle, V. Anikin, S. Begum, S. Jordan, A. Montero-Fernandez, J. Robertus, A. Rice, A. Nicholson, E. Lim
Journal: Journal of Thoracic Oncology (2019)
EP1.18-17 Pre-Radical Radiotherapy Plasma EGFR DNA Levels in Lung Cancer Patients May Predict for Early Disease Progression
Authors: B.S.H. Chia, W.L. Nei, K.W. Fong, S.P. Yap, K. Chua, C. Yip, W.L. Ng, T.R. Siow, M. Tan
Journal: Journal of Thoracic Oncology (2019)
Impact of Donor Type in Patients with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Cell Transplantation after Low-Dose TBI Based Regimen: A Study from the Acute Leukemia Working Party of the EBMT and Eurocord
Authors: Frederic Baron, Myriam Labopin, Annalisa Ruggeri, Jan J Cornelissen, Ellen Meijer, Henrik Sengeloev, Dietger Niederwieser, Marco R. de Groot, Harry C. Schouten, Noel Milpied, Didier Blaise, Bipin N. Savani, Eliane Gluckman, Mohamad Mohty, Arnon Nagler
Journal: Blood (2017)
An Integrated Analysis of Darbepoetin Alfa (DAR) in the Treatment of Anemia in Patients with Low- or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS)
Authors: Uwe Platzbecker, Argiris Symeonidis, Jeroen Simon Goede, Agnes Guerci-Bresler, Michel Delforge, Esther Natalie Oliva, Jiri Mayer, Sejal Badre, Bhakti Mehta, Cisio De Oliveira Brandao
Journal: Blood (2017)
OA12.07 Radicality of Lymphadenectomy in Lung Cancer According to Surgical Approach. Results from the Spanish Group of Video-Assisted Thoracic Surgery
Authors: C. Obiols, S. Call, R. Rami-Porta, A. Jaen, D. Gomez De Antonio, S. Crowley, I. Royo, R. Embún
Journal: Journal of Thoracic Oncology (2019)
P2.01-45 Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer
Authors: Z. Song, L. Hu, Q. Han, X. Wang, Y. Huo, T. Jiao, G. Ren, K. Wang, B. Yin, Y. Jia, J. Song, H. Cheng, H. Wang, F. Lou, S. Cao, A. Zang
Journal: Journal of Thoracic Oncology (2019)
P1.04-57 Metronomic Dosing of Chemotherapy Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Non-Small Cell Lung Cancer
Authors: Y. Jia, T. Jiang, S. Zhao, X. Li, C. Zhao, C. Zhou
Journal: Journal of Thoracic Oncology (2019)
A Phase II Multicenter Trial of HSV-TK Engineered Donor Lymphocytes after Haplo-Identical HSCT: Early Immune Reconstitution and Abrogation of Gvhd.
Authors: Chiara Bonini, Fabio Ciceri, Maria T. Lupo-Stanghellini, Attilio Bondanza, Zulma Magnani, Serena K. Perna, Massimo Bernardi, Jacopo Peccatori, Alessandra Pescarollo, Fulvio Crippa, Luciano Callegaro, Monica Salomoni, Lucia Turchetto, Salvatore Toma, Franco Aversa, Jane Apperley, Shimon Slavin, Scialini Colombi, Corrado Gallo Stampino, Marco Bregni, Claudio Bordignon
Journal: Blood (2004)
EP1.01-12 SNPs of Organic Cation Transporter 6 Associate with the Efficacy of Platinum Combination Chemotherapy
Authors: A. Takeuchi, T. Oguri, S. Fukuda, Y. Kagawa, K. Sone, O. Takakuwa, T. Uemura, K. Maeno, K. Fukumitsu, Y. Kanemitsu, H. Ohkubo, M. Takemura, Y. Ito, A. Niimi
Journal: Journal of Thoracic Oncology (2019)
Management of ulcerative colitis: summary of updated NICE guidance
Authors: Omnia Abdulrazeg, Bernadette Li, Jenny Epstein
Journal: BMJ (2019)

### What’s new in the guidance

Ulcerative colitis is a chronic inflammatory disease of the rectum and colon characterised by mucosal inflammation, resulting in symptoms of diarrhoea (both soft stool and an increased frequency of defecation), rectal bleeding, an urgent need to defecate, and abdominal pain. 

The condition usually affects the rectum and a variable extent of the colon proximal to the rectum. Inflammation of the rectum is referred to as proctitis, and inflammation of the rectum and sigmoid as proctosigmoiditis. Left sided colitis refers to disease involving the colon distal to the splenic flexure. Extensive colitis affects the colon proximal to the splenic flexure, and includes pan-colitis, where the whole colon is involved.

The most widely used drugs for inducing remission in people with mild to moderate ulcerative colitis are aminosalicylates and corticosteroids. Choice of treatment depends on the extent of disease (proctitis, proctosigmoiditis, left sided colitis, extensive colitis), mechanism of action, route of administration, site and mechanism of drug release, dose, duration, cost of treatment, and patient preference.

This article summarises recent recommendations from the update of the National Institute for Health and Care Excellence (NICE) guideline for the management of ulcerative colitis in children, young people, and adults.1 The update focuses on inducing remission in people with mild to moderate ulcerative colitis. All other areas of the guideline, such …
Ian McKim Thompson: an iconoclastic leader who helped to change the BMA
Authors: Norman Ellis
Journal: BMJ (2019)

Although Ian McKim Thompson was born in Knutsford, Cheshire, he always identified with Birmingham and the West Midlands. His father was a bank manager and his mother a medical graduate of Edinburgh (1927). His education at Epsom College with its “medical sixth form” took him to Birmingham medical school where he met his future wife (Jane Richards), a fellow student. His two younger brothers followed him at Epsom College and Birmingham medical school; Don is a GP in Peterborough, Ontario, Canada, and Alistair a retired consultant orthopaedic spine surgeon. Ian’s son, Peter, is also a consultant orthopaedic surgeon.

After qualifying Ian pursued a career in pathology, which included teaching at Birmingham University. He was a house officer at Birmingham General Hospital. He was the consultant pathologist to the Birmingham Coroner from 1966 to 1997. While working as a senior registrar in Birmingham, a growing interest and commitment to medicopolitics—fuelled by his outrage …
New Prognostic Classification for Adult T Cell Lymphoma/Leukemia Based on Hypercalcemia and Neutrophil-to-Lymphocyte Ratio
Authors: Daniel J Enriquez, Juan Carlos Haro, Patricia Rioja, Gabriel De La Cruz, Zaida Morante, Carlos Barrionuevo, Daniela Dueñas, Greenlandia Ferreyros, Judith Vidal, Rosario Retamozo, Shirley Quintana, Silvia Neciosup, Luis Mas
Journal: Blood (2017)
EP1.16-17 Management of Inappropriate Use of Opioids (IUO) in Patients (P) with Lung Cancer (LC)
Authors: T. Moran, P. Zuluaga, M. Domenech, A. Estival, E. Carcereny, L. Angelats, A. Plaja, C. Erasun, R. Muga, D. Fuster
Journal: Journal of Thoracic Oncology (2019)
P1.14-03 Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial
Authors: L. Landi, M. Tiseo, L. Heukamp, R. Menon, G. Spitaleri, D. Cortinovis, A. Delmonte, D. Galetta, M. D'Arcangelo, F. D'Incà, M. Bertrand, B. Jóri, A. Zacher, C. Gridelli, S. Novello, R. Chiari, C. Verusio, L. Crino, F. Cappuzzo
Journal: Journal of Thoracic Oncology (2019)
Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy
Authors: Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Pantelis Rousakis, Alexandra T. Argyriou, Nikolaos Kanellias, Despina Fotiou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Dimitrios C. Ziogas, Aristea-Maria Papanota, Marilyn Spyropoulou-Vlachou, Ioannis P. Trougakos, Ourania E. Tsitsilonis, Bruno Paiva, Meletios A. Dimopoulos
Journal: HemaSphere (2019)

Abstract Minimal residual disease (MRD) was monitored in 52 patients with sustained CR (≥2 years) after frontline therapy using next-generation flow (NGF) cytometry. 25% of patients initially MRD- reversed to MRD+. 56% of patients in sustained CR were MRD+; 45% at the level of 10 −5 ; 17% at 10 −6 . All patients who relapsed during follow-up were MRD+ at the latest MRD assessment, including those with ultra-low tumor burden. MRD persistence was associated with specific phenotypic profiles: higher erythroblasts’ and tumor-associated monocytes/macrophages’ predominance in the bone marrow niche. NGF emerges as a suitable method for periodic, reproducible, highly-sensitive MRD-detection at the level of 10 −6 .
International Consensus and External Validity in Global Surgery Research and Task Shifting—Reply
Authors: Jessica H. Beard, Michael Ohene-Yeboah, Jenny Löfgren
Journal: JAMA Surgery (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
Constitutive Activation of Ras and Inactivation of Ink4a/Arf Allele Induce a Fully Penetrant B-Cell Acute Lymphoblastic Leukemia Phenotype in Mice
Authors: Tomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, Sanjay Patel, Yue Kang, Ahmad Alduaij, Peter S. Dennis, Jessie Xiong, Geraldine S. Pinkus, Jeremy N. Rich, Madeleine E. Lemieux, Norman E. Sharpless, Ruben D. Carrasco
Journal: Blood (2017)
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
Authors: Alice T Shaw, Benjamin J Solomon, Rita Chiari, Gregory J Riely, Benjamin Besse, Ross A Soo, Steven Kao, Chia-Chi Lin, Todd M Bauer, Jill S Clancy, Holger Thurm, Jean-Francois Martini, Gerson Peltz, Antonello Abbattista, Sherry Li, Sai-Hong Ignatius Ou
Journal: The Lancet Oncology (2019)
Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation
Authors: Mylin A Torres, Keerthi Gogineni, David H Howard
Journal: JNCI Journal of the National Cancer Institute (2019)

In 2013, the American Society for Radiation Oncology recommended against the routine use of intensity-modulated radiation therapy (IMRT) in breast cancer patients. We evaluated trends in the use of IMRT before and after the release of the recommendation. Using Surveillance, Epidemiology, and End Results Medicare data, we identified 13 457 breast cancer patients diagnosed between 2012 and 2015 who received breast-conserving surgery and postsurgery, whole-breast, IMRT, or three-dimensional conformal radiotherapy. We find that the use of IMRT decreased by 4.6 (95% confidence interval [CI] = 3.6 to 5.6; two-sided P < .001) percentage points in hospital-based clinics. In freestanding radiotherapy clinics, which had baseline rates of IMRT use that were more than 20 percentage points higher than in hospital-based clinics, use of IMRT declined by 6.1 (95% CI = 3.5 to 8.7; two-sided P < .001) percentage points. Use of IMRT declined following the release of the recommendation, but a large share of patients treated in freestanding clinics continue to receive IMRT.
P2.01-57 New Prognostic Markers in Patients with Lung Cancer Treated with Immunoterapy: NLR and PLR
Authors: S. Gunduz, M. Ozdogan, O. Kırca, M. Çakır, A. Kargı, M. Uysal, V. Kaya, N. Öz, A. Yıldız
Journal: Journal of Thoracic Oncology (2019)
P2.14-54 High Incidence of CNS Metastases in Advanced or Recurrent Non-Small Cell Lung Cancer Patients with RET Fusion
Authors: J. Lee, B.M. Ku, J.H. Shim, Y.L. Choi, J. Sun, S. Lee, J.S. Ahn, K. Park, M. Ahn
Journal: Journal of Thoracic Oncology (2019)
P1.01-95 Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Authors: B. Han, T. Chu, X. Zhang, H. Zhong, B. Zhang, H. Wang, A. Gu, W. Zhang, C. Shi, R. Zhong
Journal: Journal of Thoracic Oncology (2019)
Lipidomics needs more standardization
Authors: Gerhard Liebisch, Robert Ahrends, Makoto Arita, Masanori Arita, John A. Bowden, Christer S. Ejsing, William J. Griffiths, Michal Holčapek, Harald Köfeler, Todd W. Mitchell, Markus R. Wenk, Kim Ekroos
Journal: Nature Metabolism (2019)
Urgent NHS reform is needed in Scotland, says auditor
Authors: Bryan Christie
Journal: BMJ (2019)

The NHS in Scotland is rapidly running out of time to reform the way care is delivered and to ensure the service can be made financially sustainable, Audit Scotland has warned.1

In its annual review of NHS performance in Scotland, Audit Scotland said that progress towards health and social care integration had been too slow and that a new national strategy was needed that supports large scale, system-wide reform from 2020 onwards.

Without change, the Scottish government’s own figures indicate that the service will run up a £1.8bn (€2.1bn; $2.3bn) shortfall by 2023-24. Extra financial …
P2.01-13 The DAIL Trial: Dietetic Assessment and Intervention in Lung Cancer
Authors: I. Phillips, A. Hug, L. Allan, N. Westran, M. Hewish, A. Mehta, L. Mainsiouw, A. Extance, B. Smith, V. Ezil, H. Saxby
Journal: Journal of Thoracic Oncology (2019)
Combined Internet-Based Cognitive-Behavioral and Chronobiological Intervention for Insomnia: A Randomized Controlled Trial
Authors: Kim Dekker, Jeroen S. Benjamins, Teodora Maksimovic, Marco Filardi, Winni F. Hofman, Annemieke van Straten, Eus J.W. Van Someren
Journal: Psychotherapy and Psychosomatics (2019)
Prenatal Exposure to Phthalates and Neurodevelopment in the CHAMACOS Cohort
Authors: Carly Hyland, Ana M. Mora, Katherine Kogut, Antonia M. Calafat, Kim Harley, Julianna Deardorff, Nina Holland, Brenda Eskenazi, Sharon K. Sagiv
Journal: Environmental Health Perspectives (2019)

Background: Previous studies suggest that prenatal exposure to phthalates, ubiquitous synthetic chemicals, may adversely affect neurodevelopment. However, data are limited on how phthalates affect cognition, executive function, and behavioral function into adolescence. Objective: We aimed to investigate associations of prenatal phthalate exposure with neurodevelopment in childhood and adolescence in the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) study. Methods: We examined associations between maternal urinary phthalate metabolite concentrations measured twice during pregnancy and a range of neurodevelopmental outcomes from ages 7 through 16 y in the CHAMACOS birth cohort (n=334). We used age-specific linear regression models and generalized estimating equation models to assess longitudinal effects and examined differences by sex. Results: Phthalate metabolites were detected in 88%–100% of samples, depending on the metabolite. Associations of phthalates with neurodevelopmental outcomes were largely null with some noteworthy patterns. Higher prenatal concentrations of metabolites of low-molecular weight phthalates (ΣLMW) were associated with more self-reported hyperactivity [β=0.8, 95% confidence interval (CI): 0.1, 1.4 per 2-fold increase in ΣLMW phthalates], attention problems (β=1.5, 95% CI: 0.7, 2.2), and anxiety (β=0.9, 95% CI: 0.0, 1.8) at age 16. We observed sex-specific differences for the sums of high-molecular-weight and di(2-ethylhexyl) metabolites and cognitive outcomes (e.g., β for Full-Scale IQ for boys=−1.9, 95% CI: −4.1, 0.3 and −1.7, 95% CI: −3.8, 0.3, respectively; β for girls=1.8, 95% CI: 0.1, 3.4 and 1.6, 95% CI: 0.0, 3.2, respectively; p-int=0.01 for both). Conclusion: We found predominantly null associations of prenatal phthalates with neurodevelopment in CHAMACOS, and weak associations of ΣLMW phthalates with internalizing and externalizing behaviors in adolescence. No previous studies have examined associations of prenatal phthalate exposure with neurodevelopment into adolescence, an important time for manifestations of effects. https://doi.org/10.1289/EHP5165
Effect of Nivolumab on Patient-Reported Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma after Autologous Transplantation: Results from the Multicohort Phase 2 Checkmate 205 Study
Authors: Andreas Engert, Fiona Taylor, Bryan Bennett, Clara Chen, Kim Cocks, Jeffrey McDonald, Erin Mann, Mariana Sacchi, David Cella
Journal: Blood (2017)
MA18.02 S100A10 Upregulation Associates with Poor Prognosis in Lung Squamous Cell Carcinoma
Authors: K. Sato, Y. Saiki, K. Arai, K. Ishizawa, S. Fukushige, A. Sakurada, Y. Okada, A. Horii
Journal: Journal of Thoracic Oncology (2019)
Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective
Authors: Muddassir Mehmood
Journal: American Journal of Respiratory and Critical Care Medicine (2019)

In a recent issue of the Journal, Ayas and colleagues put their finger on the pulse of cardiovascular (CV) interactions in obstructive sleep apnea (OSA) (1).The authors eloquently highlighted the pathophysiologic bases of the adverse effect of chronic intermittent hypoxia marked by proinflammatory and adverse neurohormonal effects and raised the important question of whether adjunctive pharmacotherapy could alter CV outcomes in OSA (1).In this context, it is important to remind the scientific community that the effect of such cardiopulmonary interactions extends beyond OSA.This is particularly relevant for chronic obstructive pulmonary disease (COPD) and heart failure with preserved ejection fraction (HFpEF), two diseases that often coexist and adversely impact outcomes (2).Chronic inflammation plays a central role in COPD, and in addition to pulmonary manifestations, is characterized by systemic inflammation with potential adverse CV impact (3).Indeed, inflammation and heart failure are strongly interconnected, and in HFpEF, the proinflammatory state is driven by comorbidities (4).Although blockage of the renin-angiotensin system exerts multisystem antiinflammatory effects, renin-angiotensin system inhibition and multiple other drug classes have not shown improvement in prespecified endpoints in HFpEF trials, thus highlighting the need for better patient selection (5).In this regard, COPD and OSA appear to be prime avenues for a precision medicine approach to HFpEF.However, identifying patients most suited for tailored adjuvant pharmacotherapy for the prevention and management of HFpEF is made challenging by confounding factors, as discussed by Ayas and colleagues (1).Encouragingly, precision medicine in HFpEF is gaining traction, with a focus on diabetes, and the cardiopulmonary community can learn from this.Most recently, machine learning has been incorporated to predict the risk for heart failure in type 2 diabetes, using readily available clinical variables ( 6).An integrated cardiopulmonary approach leveraging machine learning may be the next best step to investigate the role of adjuvant pharmacotherapy in COPD, OSA, and HFpEF.As a scientific community, we cannot and should not delay a multidisciplinary approach to solving important multisystem problems.
Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib
Authors: Ellen K Ritchie, Rosalind Catchatourian, Rebecca B. Klisovic, Javier Pinilla-Ibarz, Michael W. Deininger, Harry P. Erba, Jerald P. Radich, Michael R. Savona, Ilva Dautaj, Das Purkayastha, Karen Habucky, Michael J. Mauro
Journal: Blood (2017)
Suboptimal care contributed to deaths of 10 cancer patients treated in “dysfunctional” urology department, coroner finds
Authors: Clare Dyer
Journal: BMJ (2019)

A coroner has criticised an NHS trust for “suboptimal care” and “missed opportunities” in the treatment of 10 patients with cancer at a urology department where relationships were “dysfunctional.”

Coroner Penelope Schofield said that all 10 had died of natural causes but that missed opportunities, suboptimal care, and in three cases “neglect” had contributed to the deaths.

The patients, who died from prostate or bladder cancer from 2006 to 2015, were under the care of Paul Miller, a consultant urologist at East Surrey Hospital in Redhill. He was sacked by Surrey and Sussex Healthcare NHS Trust in 2014 over …
MA15.05 Computerized Measurements of Cellular Diversity on H&amp;E Tissue Are Prognostic of OS and Associated with Mutational Status in NSCLC
Authors: V. Velcheti, C. Lu, K. Bera, X. Wang, P. Fu, M. Yang, D. Rimm, K. Schalper, A. Madabhushi
Journal: Journal of Thoracic Oncology (2019)
P1.01-59 Expanding Access to Large-Scale Genomic Mutational Analyses for Patients with Advanced NSCLC in Italy
Authors: V. Gregorc, C. Lazzari, A. Guida, G. Bucci, P. Graziano, M.G. Cangi, G. Frigè, A. Rossi, A. Ceol, D. Sardina, M. Milella, M. Pallocca, P. Vigneri, L. Fancello, S. Buglioni, G. Motta, T. Biagini, E. Rijavec, S. Bonfiglio, A. Delmonte, L. Toschi, G. Banna, D. Galetta, A. Bearz, A. Tartarone, F. Verderame, M. Daidone, M. Fanciulli, G. Ciliberto, P.G. Pelicci, R. De Maria, L. Mazzarella
Journal: Journal of Thoracic Oncology (2019)
EP1.01-32 Improving the Prognosis of Non-Small Cell Lung Cancer After the Approval of Immune Checkpoint Inhibitors: A Retrospective Analysis
Authors: T. Yamaguchi, Y. Oya, H. Furuta, N. Watanabe, T. Uemura, J. Shimizu, Y. Horio, T. Hida
Journal: Journal of Thoracic Oncology (2019)